Compass Therapeutics Inc. (CMPX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | ANDERMAN, JONATHAN | General Counsel | Common Stock | Acquisition | 25,000 | 1.89 |
| Apr 29, 2026 | LERNER, NEIL | Chief Accounting Officer | Common Stock | Acquisition | 15,000 | 1.89 |
| Feb 8, 2026 | SCHUETZ, THOMAS J. | Director, CHIEF EXECUTIVE OFFICER | Common Stock | Disposal | 36,687 | 6.52 |
| Jan 9, 2026 | SCHUETZ, THOMAS J. | Director, CHIEF EXECUTIVE OFFICER | Common Stock | Disposal | 46,777 | 5.35 |
| Jan 2, 2026 | ANDERMAN, JONATHAN | General Counsel | Stock Option (Right to Buy) | Acquisition | 720,000 | 0 |
| Jan 2, 2026 | PRASAD, ARJUN | Chief Commercial Officer | STOCK OPTION (RIGHT TO BUY) | Acquisition | 1,000,000 | 0 |
| Jan 2, 2026 | GRAY, MARY ANN | Director | Stock Option (Right to Buy) | Acquisition | 90,000 | 0 |
| Jan 2, 2026 | GORDON, CARL L | Director | Stock Option (Right to Buy) | Acquisition | 90,000 | 0 |
| Jan 2, 2026 | ANDERMAN, JONATHAN | General Counsel | Common Stock | Acquisition | 150,000 | 5.17 |
| Jan 2, 2026 | LERNER, NEIL | Chief Accounting Officer | Common Stock | Acquisition | 62,500 | 5.17 |
| Jan 2, 2026 | LERNER, NEIL | Chief Accounting Officer | Stock Option (Right to Buy) | Acquisition | 435,000 | 0 |
| Jan 2, 2026 | SCHUETZ, THOMAS J. | Director, CEO | Common Stock | Acquisition | 250,000 | 5.17 |
| Jan 2, 2026 | SHIN, BARRY | CFO | Common Stock | Acquisition | 125,000 | 5.17 |
| Jan 2, 2026 | LINDAHL, RICHARD S | Director | Stock Option (Right to Buy) | Acquisition | 90,000 | 0 |
| Jan 2, 2026 | BOYLAN, JAMES P | Director | Stock Option (Right to Buy) | Acquisition | 90,000 | 0 |
| Jan 2, 2026 | SCHUETZ, THOMAS J. | Director, CEO | Stock Option (Right to Buy) | Acquisition | 2,000,000 | 0 |
| Jan 2, 2026 | FERNEAU, PHILIP | Director | Stock Option (Right to Buy) | Acquisition | 90,000 | 0 |
| Jan 2, 2026 | CHINIARA, ELLEN | Director | Stock Option (Right to Buy) | Acquisition | 90,000 | 0 |
| Jan 2, 2026 | SHIN, BARRY | CFO | Stock Option (Right to Buy) | Acquisition | 670,000 | 0 |
| Jan 2, 2026 | SIRARD, CYNTHIA | Chief Medical Officer | STOCK OPTION (RIGHT TO BUY) | Acquisition | 1,000,000 | 0 |
| Nov 16, 2025 | SCHUETZ, THOMAS J. | Director, CHIEF EXECUTIVE OFFICER | Common Stock | Disposal | 44,025 | 4.83 |